|
Ceara McNiff, MD, was a neonatal-perinatal fellow from 2005 - 2008. Dr. McNiff is currently employed by Boston Children's Hospital's Newborn Medicine Division, and works full-time at Beverly Hospital in the Special Care Nursery doing clinical care. Dr. McNiff also co-directs the Community Outreach Program for the Newborn Medicine Division. At Beverly Hospital, she is a member of the Perinatal Committee. Dr. McNiff lives in Gloucester with her husband, Vincent, and new son, Finn, born this summer.
Juliette C. Madan, MD, MS, was a neonatal-perinatal fellow from 2003-2006. Dr. Madan’s fellowship project was PDA research; She did two projects (one and a half then finished as a first year attending the second one) looking at PDA and its treatment and the association between PDA therapy, gestational age, likelihood of success of therapy and GI complications potentially related. Dr. Madan’s second project was the NRN study of PDA therapy and long term neurodevelopmental impairment, NEC and BPD. The first was published in Neonatology in 08, the second in Pediatrics in ‘09. During fellowship Dr. Madan was a fellow in the Clinical Research Program at Tufts and received my masters degree in science in clinical research. Since fellowship, Dr. Madan was an attending for 2 years at Tufts doing clinical research with the NRN as above, and work on maternal obesity and neonatal outcomes (3-4 publications). In the past year, Dr. Madan transitioned to Dartmouth Hitchcock Medical Center where she is 70% research 30% clinical, and her research focus is the developing microbiome in infants (premature infants and infants with CF) and correlating respiratory and GI microbial colonization with health and disease. Dr. Madan currently has a 2 year career development grant as well as 3 foundation grants that support her research, and will be applying for K23 in 2010.
Jill Maron, MD, MPH, was a fellow in Newborn Medicine from 2003-2006. During her fellowship, she conducted research on fetal gene trafficking in the maternal circulation at term gestation under the guidance of her mentor Dr. Diana Bianchi. This work laid the foundation for her continued ongoing collaboration with Dr. Bianchi and sparked in her interest in the genomics and proteomics of the developing fetus and premature neonate. She is the recipient of multiple research grants including the Natalie V. Zucker Women in Science Award, the Tufts Pediatric Research Grant and the Charles H. Hood Foundation grant. She is also the recipient a NICHD K08 Career Mentor Scientific Development award which provides funding for genomic salivary analysis on premature infants to noninvasively monitor their development, assess feeding tolerance, and attempt to identify novel biomarkers associated with unique disease processes in this vulnerable patient population. She has presented her work at numerous national and international conferences and has authored several papers, a review article and a book chapter since the start of her fellowship at Tufts Medical Center.
Philip Pan, MD, was a neonatal-perinatal fellow from 2001 - 2004. He is now the associate director of neonatology at Bellevue Woman's Center a level 2+ NICU in Schenectady, NY and an assistant clinical professor in neonatology at Albany Medical Center the regional perinatal level 3 NICU in Albany, NY. Dr. Pan’s interests include primarily clinical neonatology and genetic disorders and administrative duties including billing, coding, and statistics. His practices are actively involved in resident training and nursing education. At Tufts, Dr. Pan worked with Dr. Diana Bianchi studying serum cff-DNA in IVF-conceived pregnancies. cff-DNA appeared to be independent of other traditional serum screening markers and may be used as an additional marker for risk assessment of fetal Down syndrome.
Together with colleagues from the ELGAN study, Kristi Washburn-Tolsma explored whether early or late and presumed or definite neonatal bacteremia are associated with an increased risk of severe retinopathy of prematurity (ROP). She analyzed data from 1059 infants born before week 28 of gestation and found that definite late neonatal bacteremia seems to be an independent risk factor for prethreshold/threshold ROP and plus disease, and presumed late bacteremia seems to be related to prethreshold/threshold ROP. The resulting paper (http://www.ncbi.nlm.nih.gov/pubmed?term=22159674) was published in the prestigious journal ARCHIVES OF OPHTHALMOLOGY and selected as one of the highlighted papers in the month of December 2011.
|